Skip to main content

Clinical trial Ro-CHOP

RoCHOP Phase 3 multi-center randomized study to compare efficacy and safety of Romidepsin-CHOP (Ro-CHOP) versus CHOP in subjects with previously untreated peripheral T-Cell Lymphoma

Cancers
Organ Lymphoma
Trial status Trial closed
Investigator
Trial type
Interventional with experimental drug
Phase Trial phase 3
Academic trial Non
EudraCT Identifier 2012-001580-68
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT01796002
Inclusion criteria histologically proven peripheral T-cell lymphoma (PTCL)
Last update